TransMedics Group, Inc. Piotroski F-Score
TMDX / Health Care|Based on FY2025 SEC 10-K data
TransMedics Group, Inc.'s Piotroski F-Score of 6/9 suggests moderate financial health, passing 6 of 9 criteria (FY2025). The score evaluates profitability, leverage, and operating efficiency from TransMedics Group, Inc.'s SEC 10-K filing.
Based on SEC 10-K filings.
Moderate financial health
The Piotroski F-Score evaluates financial strength using 9 binary criteria across profitability, leverage, and operating efficiency. Learn how it works
Profit margin ranks in the above average of Health Care companies
What This Score Means
TransMedics Group, Inc. scores 6/9 on the Piotroski F-Score based on FY2025 SEC 10-K data. All four profitability criteria are met, indicating strong earnings quality with positive net income, cash flow, improving returns, and earnings backed by operating cash flow. Leverage and liquidity show no improvement (0/3 criteria met). Both operating efficiency metrics (gross margin and asset turnover) improved year-over-year.
The Piotroski F-Score is a financial strength indicator based on 9 binary criteria from SEC 10-K filings. Scores of 8-9 suggest strong fundamentals, while 0-2 may indicate financial weakness. This is not investment advice.
9-Criterion Breakdown
1. Positive Net Income
Net Income > 0
2. Positive Operating Cash Flow
Operating Cash Flow > 0
3. ROA Increase
Return on Assets improved year-over-year
4. Quality of Earnings
Operating Cash Flow > Net Income
5. Leverage Decrease
Debt-to-assets ratio decreased or unchanged
6. Current Ratio Increase
Current ratio improved year-over-year
7. No Share Dilution
Shares outstanding did not increase
8. Gross Margin Increase
Gross margin improved year-over-year
9. Asset Turnover Increase
Revenue / Total Assets improved
As of FY2025 · SEC 10-K · Updated Feb 28, 2026